Bristol-Myers Squibb Co (LTS:0R1F)
$ 54.48 -1.095 (-1.97%) Market Cap: 109.81 Bil Enterprise Value: 153.11 Bil PE Ratio: 0 PB Ratio: 6.41 GF Score: 84/100

Bristol-Myers Squibb Co at TD Cowen Health Care Conference Transcript

Mar 04, 2024 / 02:50PM GMT
Release Date Price: $51.08 (+0.34%)
Stephen Michael Scala
TD Cowen, Research Division - MD & Senior Research Analyst

Well, good morning once again. We're delighted to have Bristol-Myers Squibb here at the Cowen 44th Annual Healthcare Conference. Representing the company is Roland Chen, who is Senior Vice President and Head of Immunology, Cardiology, or Cardiovascular, and Neuroscience Development. So thank you so much for making the effort to be with us.

Roland Chen

Thanks, Steve.

Questions & Answers

Stephen Michael Scala
TD Cowen, Research Division - MD & Senior Research Analyst

You're in charge of three critical areas to the outlook for Bristol-Myers Squibb. Just tell us in a very brief fashion, what is the central objective in each of these three areas, say, for the next 3 to 5 years?

Roland Chen

Yes. So thanks for that question, Steve. It's a pleasure to be here. I think if I just think about the three areas, I mean let me start with cardiovascular. I think where we are focused is in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot